Inqovi Tablet, Film Coated
Product Images NDC 64842-0727

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Inqovi (NDC 64842-0727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Taiho Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Inqovi 01)

Chemical structure diagram of cedazuridine, one of the active ingredients in INQOVI (cedazuridine and decitabine). The structure shows atoms including fluorine, oxygen, nitrogen, and carbon arranged in the molecular configuration.*

FDA Label Image

Chemical Structure (Inqovi 02)

Chemical structure diagram of the active ingredient Decitabine from the product INQOVI, showing its molecular configuration including the hydroxyl groups, nitrogenous base, and sugar moiety.*

FDA Label Image

Principal Display Panel (35 mg/100 mg Tablet Carton)

Packaging label for INQOVI tablets, containing 35 mg cedazuridine and 100 mg decitabine per tablet. The film-coated oral tablets are provided by Taiho Pharmaceutical Co., Ltd. The label displays dosage strength, the proprietary and generic names, blister card instructions, cautions about hazardous agents, and the product NDC 64842-0727.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.